EAACI Congress 2025
BackL-OAS02 - Dermatology
Friday 13 Jun, 09:00 AM -
10:00 AM Glasgow, United Kingdom
Carron 2
Oral Abstract Sessions
09:00
Skin microbiome and eczema
09:12
Sustained Disease Control Following Withdrawal of Barzovolimab in Patients with Chronic Spontaneous Urticaria
09:24
Rocatinlimab Significantly Improves Clinical Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis by Specifically Reducing OX40R+ T-Cell Population Without Signs of Immunosuppression
09:36
Higher body mass index in childhood is associated with skin barrier dysfunction in adolescence: findings in a population-based birth cohort
09:48
Atopic Dermatitis severity correlation with Staphylococcus aureus as function of demographic and environmental factors
